glp-1 receptor agonists blindness risk GLP 1 Ozempic linked to higher risk

At 10 nmol/l Ex-4 inhibits IB-phosphorylation and prevents NF-B/p65 nuclear translocation, halving tumor necrosis factor alpha (TNF-) and IL-6 both intracellularly and in the medium [19], thereby attenuating pro-inflammatory signaling and enhancing hMSC viability under inflammatory conditions

Smaller meals, steady hydration, and dietary fiber help with the common gut symptoms

The review also identifies gaps in knowledge, suggesting future research directions for optimizing patient selection and treatment regimens to maximize therapeutic benefits

The biggest takeaway

Semaglutide is marketed as Ozempic for diabetes and Wegovy for weight loss

Postoperative Considerations Postoperative care should be individualized according to symptoms, procedure type, diabetes status, and the reason for GLP-1 therapy